BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 3, 2009
View Archived Issues
Let the Testing Begin: NIH OKs 13 Embryonic Stem Cell Lines
WASHINGTON - The Obama administration Wednesday approved the first 13 human embryonic stem cell (hESC) lines eligible for use in government-funded research under new guidelines adopted in July. (BioWorld Today)
Read More
Hemispherx Down on Ampligen FDA Rejection, but not yet Out
Read More
Dyax's Kalbitor OK'd; Berinert Could Be Hurt in Acute HAE
Read More
Phenomix Secures Partner for DPP-4 Inhibitor in $163M Deal
Read More
Chaperone Gets a Lift: CytRx's ALS Drug Back to Clinic at Last
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Financings Roundup
Read More
U.S. Patent Disclosures
Read More